文献速递慢阻肺哮喘

慢性气道疾病的Th-2特征:迈向哮喘-慢阻肺重叠综合征的终结?

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
PubMed 文献 · Eur Respir J · 2017-05-01

该横断面研究纳入292例年龄≥40岁、支气管舒张后FEV1/FVC≤0.7且既往诊断哮喘、慢阻肺或哮喘-慢阻肺重叠综合征的患者,比较经典诊断标签与基于Th-2炎症特征(Th-2高或低)分类的差异。结果显示经典诊断组间症状和急性加重率无差异,而Th-2特征分类在人口学、功能和炎症特征上差异显著,提示基于炎症特征的分类能更清晰区分慢性阻塞性气道疾病患者。

要点

  • 经典诊断标签(哮喘、慢阻肺、ACOS)间症状和急性加重率无差异。
  • Th-2高特征见于49%非吸烟哮喘、3.3%慢阻肺、30%吸烟哮喘和49.3%嗜酸性慢阻肺患者。
  • 基于炎症特征的分类比经典诊断标签更能区分患者特征。

核心结论

  • 基于炎症特征而非传统诊断标签的分类能更清晰区分慢性阻塞性气道疾病患者。

研究设计与样本

  • 横断面研究纳入292例年龄≥40岁、支气管舒张后FEV1/FVC≤0.7且既往诊断哮喘、慢阻肺或ACOS的患者。
  • ACOS组包括吸烟哮喘患者和嗜酸性慢阻肺患者。
  • 比较各组临床、功能和炎症参数,Th-2特征定义为血嗜酸性粒细胞≥300 cells·μL-1和/或痰嗜酸性粒细胞≥3%。

主要发现

  • 三组经典诊断标签间症状或急性加重率无差异。
  • 94例(32.2%)为Th-2高特征,198例(67.8%)为Th-2低特征。
  • Th-2特征见于49%非吸烟哮喘、3.3%慢阻肺、30%吸烟哮喘和49.3%嗜酸性慢阻肺患者。
  • 基于炎症特征的分类在人口学、功能和炎症特征上产生显著差异。

关键数值与推荐

  • Th-2特征定义为血嗜酸性粒细胞≥300 cells·μL-1和/或痰嗜酸性粒细胞≥3%。

临床怎么用

  • 临床可考虑基于血或痰嗜酸性粒细胞等炎症标志物对慢性气道疾病患者进行Th-2特征分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to describe the differences and similarities between patients with chronic obstructive airway disease classified on the basis of classical diagnostic labels (asthma, chronic obstructive pulmonary disease (COPD), or asthma-COPD overlap (ACOS)) or according to the underlying inflammatory pattern (Th-2 signature, either Th-2-high or Th-2-low).We performed a cross-sectional study of patients aged ≥40 years and with a post-bronchodilator forced expiratory volume in 1 s to forced vital capacity ratio ≤0.7 with a previous diagnosis of asthma (non-smoking asthmatics (NSA)), COPD or ACOS, the latter including both smoking asthmatics (SA) and patients with eosinophilic COPD (COPD-e). Clinical, functional and inflammatory parameters (blood eosinophil count, IgE and exhaled nitric oxide fraction (FeNO)) were compared between groups. Th-2 signature was defined by a blood eosinophil count ≥300 cells·μL-1 and/or a sputum eosinophil count ≥3%.Overall, 292 patients were included in the study: 89 with COPD, 94 NSA and 109 with ACOS (44 SA and 65 with COPD-e). No differences in symptoms or exacerbation rate were found between the three groups. With regards the underlying inflammatory pattern, 94 patients (32.2%) were characterised as Th-2-high and 198 (67.8%) as Th-2-low. The Th-2 signature was found in 49% of NSA, 3.3% of patients with COPD, 30% of SA and 49.3% of patients with COPD-e. This classification yielded significant differences in demographic, functional and inflammatory characteristics.We conclude that a classification based upon the inflammatory profile, irrespective of the taxonomy, provides a more clear distinction of patients with chronic obstructive airway disease.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Cosío BG, Pérez de Llano L, Lopez Viña A, et al. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome? Eur Respir J. 2017. PMID: 28461299. doi:10.1183/13993003.02397-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。